Search

Despite the rapid development of mobile health based on wearable devices in recent years, lack of access to biochemical detection remains a vital challenge for most commercial wearable devices, which hinders the provision of effective electronic health records (EHRs) for disease control strategies, and further constraining the development of personalized precision medicine. Herein, we propose a strategy to graft biochemical detection function onto commercial bracelet. Different from the conventional development process of designing a completely new wearable biochemical device, we prefer to upgrade existing commercial wearable device to achieve simpler, faster, and more effective research and commercialization processes. An affordable and user-friendly biochemical button module has been designed that enables to integrate sensitive, specific, and rapid biochemical detection function into the idle space on the strap of the bracelet without increasing the size of the main body. This "Smart Bracelet Plus" shows the ability to simultaneously monitor physical and biochemical signals, and will serve as a reliable and systematic personal diagnostics and monitoring platform for providing real-time EHRs for disease control strategies and improving the efficiency of the healthcare system., Competing Interests: Declaration of competing interest Xunshun Tao have a significant interest in Nanjing Ziqishun Biotechnology Co., Ltd, a company that have a commercial interest in the detailed mechanical and electrical design of this system. The potential individual conflict of interest has been reviewed and managed by South China University of Technology. Junhao Chen and Junfei Tian have potential interest in the results of this research and technology. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)

Revolutionary all-in-one RPA-CRISPR assays are rapidly becoming the most sought-after tools for point-of-care testing (POCT) due to their high sensitivity and ease of use. Despite the availability of one-pot methods for specific targets, the development of more efficient methods for new targets remains a significant challenge. In this study, we present a rapid and universal approach to establishing an all-in-one RPA-Cas12a method CORDSv2 based on rational balancing amplification and Cas12a cleavage, which achieves ultrasensitive detection of several targets, including SARS-CoV-2, ASFV, HPV16, and HPV18. CORDSv2 demonstrates a limit of detection (LOD) of 0.6 cp/μL and 100% sensitivity for SARS-CoV-2, comparable to qPCR. Combining with our portable device(hippo-CORDS), it has a visual detection LOD of 6 cp/μL and a sensitivity up to 100% for SARS-CoV-2 and 97% for Ct<35 ASFV samples, surpassing most one-pot visual methods. To simplify and accelerate the process for new targets, we also develop a de novo autodesigner by which the optimal couples of primers and crRNA can be selected rapidly. As a universal all-in-one RPA-CRISPR method for on-site testing, CORDSv2 becomes an attractive choice for rapid and accurate diagnosis in resource-limited settings., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Fast and accurate detection of S. aureus and effectively kill S. aureus in the bloodstream in low doses acted as key roles in medicine and microbiology studies. In this work, sufonated-hyaluronic acid (S-HA) terminated magnetic mesoporous silica nanoparticles (MMSNs) loaded with vancomycin was successfully prepared, and S. aureus antibody was further modified on the surface of MMSNs (Ab@S-HA@MMSNs) by amidation reaction. The result showed that Ab@S-HA@MMSNs were 240 nm-sized spheres with worm-like mesoporous channels. With the aid of magnetic interaction, Ab@S-HA@MMSNs were modified on the surface of magnetic glassy carbon electrode (MGCE). This prepared immunosensor exhibited an excellent detection limit and linear range, and possessed good selectivity, stability and reproducibility. Besides, since the S-HA terminated MMSNs have anticoagulant property, the Ab@S-HA@MMSNs/MGCE showed antiadhesion property, which ensure that it can be directly applied to detect the amount of S. aureus in whole blood. What's more, with an increasing amount of S. aureus arriving at MGCE, the capping Ab@S-HA@MMSNs were degraded by Hyal which was secreted by S. aureus, and the packaged vancomycin was subsequently released. Ultimately, S. aureus can be effectively killed. Therefore, this integrated platform would be a promising multifunctional platform for achieving accurate diagnosis and efficient treatment of S. aureus bloodstream infection., (Copyright © 2019 Elsevier B.V. All rights reserved.)

The conventional test strip has usually only one electrochemical reaction channel, which requires two times figure punctures for the self-management of patients suffering from both diabetes and gout. Considering the large number of such patients and for the sake of reducing their pains, we report an enzymatic test strip which can simultaneously monitor glucose and uric acid (UA) with only one fingertip blood droplet. The proposed test strip is composed of dual channels. The glucose in blood is detected in the 1st channel above on the substrate and the UA is characterized in the 2nd channel located at the bottom of the substrate. The proposed design intensively matches the requirement of those patients simultaneously suffering from diabetes and gout. We carried out comparative investigations on the proposed test strip and clinical biochemical analyser, which indicates a good agreement and proved the reliability and accuracy of the proposed test strip, as promising solution for the fast growth of family health management market., (Copyright © 2017 Elsevier B.V. All rights reserved.)